Literature DB >> 22105160

Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice.

Hiroko Makihara1, Tsutomu Shimada, Eriko Machida, Masatomi Oota, Rika Nagamine, Masahito Tsubata, Kaoru Kinoshita, Kunio Takahashi, Masaki Aburada.   

Abstract

Visceral obesity induces insulin resistance and is recognized as an important risk factor for metabolic syndrome (MS). Therefore, inhibition of lipid absorption from the intestine is regarded as an effective way of preventing MS. Terminalia bellirica is extensively used in Ayurvedic medicine in India and neighboring countries, and the fruit of this plant has been reported to have hypoglycemic and hypolipidemic effects. In this study, we investigated the preventive effect of a hot water extract of T. bellirica fruit (TB) on obesity and various metabolic disorders, and explored its molecular mechanisms and active ingredients. TB treatment had a preventive effect on obesity, insulin resistance, and hyperlipidemia in spontaneously obese type 2 diabetic TSOD mice. To clarify the molecular mechanisms of TB in preventing obesity, we investigated the inhibitory effect on lipid absorption. TB suppressed absorption of triacylglycerol in an olive oil loading test (in vivo) and showed a strong inhibitory effect on pancreatic lipase activity (in vitro). Furthermore, a search for the active ingredients in TB revealed that gallic acid is the component primarily responsible for the inhibition of pancreatic lipase activity. Thus, our findings indicate that TB could be useful in preventing MS. The mechanisms probably involve suppression of the absorption of meal-derived lipids mediated by gallic acid.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105160     DOI: 10.1007/s11418-011-0606-y

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  35 in total

1.  Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats.

Authors:  R Cecily Rosemary Latha; P Daisy
Journal:  Chem Biol Interact       Date:  2010-11-13       Impact factor: 5.192

2.  A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.

Authors:  Bethany D Freedman; Eun-Jig Lee; Youngkyu Park; J Larry Jameson
Journal:  J Biol Chem       Date:  2005-02-15       Impact factor: 5.157

3.  Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis.

Authors:  H P Shaila; S L Udupa; A L Udupa
Journal:  Int J Cardiol       Date:  1998-12-01       Impact factor: 4.164

4.  A new mouse model of spontaneous diabetes derived from ddY strain.

Authors:  W Suzuki; S Iizuka; M Tabuchi; S Funo; T Yanagisawa; M Kimura; T Sato; T Endo; H Kawamura
Journal:  Exp Anim       Date:  1999-07

5.  Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats.

Authors:  Chin-Lin Hsu; Gow-Chin Yen
Journal:  Br J Nutr       Date:  2007-05-03       Impact factor: 3.718

6.  Antidiabetic and antioxidant activity of Terminalia belerica. Roxb.

Authors:  M C Sabu; Ramadasan Kuttan
Journal:  Indian J Exp Biol       Date:  2009-04       Impact factor: 0.818

7.  Carnosic acid, a new class of lipid absorption inhibitor from sage.

Authors:  Kiyofumi Ninomiya; Hisashi Matsuda; Hiroshi Shimoda; Norihisa Nishida; Naoki Kasajima; Tomoe Yoshino; Toshio Morikawa; Masayuki Yoshikawa
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

8.  Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice.

Authors:  Aera Jang; Periasamy Srinivasan; Na Young Lee; Hyun Pa Song; Ju Woon Lee; Mooha Lee; Cheorun Jo
Journal:  Chem Biol Interact       Date:  2008-05-18       Impact factor: 5.192

9.  Preventive effects of Bofutsushosan on obesity and various metabolic disorders.

Authors:  Tsutomu Shimada; Toshiyuki Kudo; Tomoko Akase; Masaki Aburada
Journal:  Biol Pharm Bull       Date:  2008-07       Impact factor: 2.233

10.  Preventive actions of Terminalia belerica in experimentally induced atherosclerosis.

Authors:  H P Shaila; A L Udupa; S L Udupa
Journal:  Int J Cardiol       Date:  1995-04       Impact factor: 4.164

View more
  4 in total

Review 1.  Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies.

Authors:  Luciano Mamede de Freitas Junior; Eduardo B de Almeida
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Terminalia bellirica (Gaertn.) Roxb. Extract and Gallic Acid Attenuate LPS-Induced Inflammation and Oxidative Stress via MAPK/NF-κB and Akt/AMPK/Nrf2 Pathways.

Authors:  Miori Tanaka; Yoshimi Kishimoto; Mizuho Sasaki; Akari Sato; Tomoyasu Kamiya; Kazuo Kondo; Kaoruko Iida
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

3.  Clinical Evaluation of a Novel Tablet Formulation of Traditional Thai Polyherbal Medicine Named Nawametho in Comparison with Its Decoction in the Treatment of Hyperlipidemia.

Authors:  Patcharawalai Jaisamut; Channong Tohlang; Subhaphorn Wanna; Acharaporn Thanakun; Thawatchai Srisuwan; Surasak Limsuwan; Wissava Rattanachai; Jarinee Suwannachot; Sasitorn Chusri
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

4.  Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro.

Authors:  Miori Tanaka; Yoshimi Kishimoto; Emi Saita; Norie Suzuki-Sugihara; Tomoyasu Kamiya; Chie Taguchi; Kaoruko Iida; Kazuo Kondo
Journal:  Antioxidants (Basel)       Date:  2016-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.